Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|September 27, 2012

Supplements and Featured Publications

Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Re
Volume 18
Issue 8 Suppl

Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Download PDF: Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Articles in this issue

over 13 years ago

Article

Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

over 13 years ago

Article

Participating Faculty: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC original research policy

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

AJMC original research clinical

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

AJMC original research managerial

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

AJMC trends from the field

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Trending on AJMC

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose

United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol